- €32.09bn
- €36.52bn
- €18.43bn
- 52
- 22
- 95
- 58
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18,401 | 15,371 | 16,192 | 17,569 | 18,428 |
Cost of Revenue | |||||
Gross Profit | 4,524 | 3,580 | 4,033 | 4,455 | 4,766 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 16,757 | 14,683 | 14,896 | 16,068 | 17,107 |
Operating Profit | 1,644 | 688 | 1,296 | 1,501 | 1,322 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,447 | 514 | 1,165 | 1,347 | 1,181 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,146 | 450 | 1,017 | 1,122 | 929 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 1,122 | 483 | 1,089 | 1,121 | 1,023 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,122 | 483 | 1,089 | 1,121 | 1,023 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.7 | 3.33 | 4.76 | 5.66 | 6.66 |
Dividends per Share |